← Back to Search

Behavioral Intervention

Positive Parenting Program for Child Behavioral Disorders in Foster Care

N/A
Recruiting
Led By Joanne N Wood, MD, MSHP
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up (4-10 wks post-intervention)
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates a program to help foster caregivers positively parent and feel more empathy.

Who is the study for?
This trial is for foster caregivers over 18 years old who speak English and are parenting a foster child aged between 2 to 10. They must be willing to give informed consent to participate in the study.
What is being tested?
The trial is testing PriCARE, a program aimed at improving parenting skills and empathy among foster parents dealing with children's disruptive behaviors and mental health issues.
What are the potential side effects?
Since PriCARE is a positive parenting program rather than a medical intervention, it does not have physical side effects. However, participants may experience emotional or psychological responses as they learn new strategies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants enrolled in PriCARE intervention
Rate of participant attendance to PriCARE training sessions
Retention rate of participants in PriCARE
Secondary study objectives
Change in Adult-Adolescent Parenting Inventory-2 (AAPI-2) score between baseline and follow-up visit
Change in Parenting Scale score between baseline and follow-up visit
The change in Parenting Sense of Competence score between baseline and follow-up visit
+2 more
Other study objectives
Description of study groups

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All participants who enroll in the study will be assigned to a PriCARE group program that will adhere to the approximately 9 hour PriCARE curriculum.The trainings are administered to groups of approximately 4-12 caregivers at a time and are led by 2 mental health providers trained in the PriCARE curriculum. The curriculum will be delivered in 2-6 sessions over a 2-20 week period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PriCARE
2016
N/A
~440

Find a Location

Who is running the clinical trial?

Ray E. Helfer SocietyUNKNOWN
Children's Hospital of PhiladelphiaLead Sponsor
729 Previous Clinical Trials
8,470,251 Total Patients Enrolled
Joanne N Wood, MD, MSHPPrincipal InvestigatorChildren's Hospital of Philadelphia
2 Previous Clinical Trials
439 Total Patients Enrolled

Media Library

PriCARE (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03910491 — N/A
Behavioral disorders Research Study Groups: Intervention
Behavioral disorders Clinical Trial 2023: PriCARE Highlights & Side Effects. Trial Name: NCT03910491 — N/A
PriCARE (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03910491 — N/A
~6 spots leftby Jul 2025